Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Using Passive Antibody Therapies in the Next Pandemic.
Curr Top Microbiol Immunol
December 2024
Department of Molecular Microbiology and Immunology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
The twenty-first century has witnessed seven human viral pandemics. Approximately once every three to four years over the past quarter-century, the world has experienced a new viral epidemic that expanded well beyond its original national borders to become a pandemic. The probability that another pandemic caused by a previously unknown agent will occur in the near future is thus very high and public health agencies must prioritize mechanisms for detecting their first signals.
View Article and Find Full Text PDFDesign and implementation of a Primary Health Care (PHC) Toolbox for improving the impact of support from Global Development Partners.
BMC Glob Public Health
April 2024
World Health Organization Headquarters, Special Program on Primary Health Care, Geneva, Switzerland.
Primary Health Care (PHC) is the most equitable and cost-effective way to enhance the health of populations and improve health security and is a requirement for achieving universal health coverage (UHC). Vital to advancing the PHC agenda is effective global health partnerships, particularly with Global Health Initiatives (GHIs) which provide financial support for improving population health. Despite progress, GHI support at times remained parallel to rather than embedded in national health strategies.
View Article and Find Full Text PDFStrengthening the fight against CLABSI: Insights from comparative study of UVC vs PICC line: Author's Reply.
Indian Pediatr
December 2024
Consultant Neonatologist, Paramitha Children's Hospital, Hyderabad, Telangana 500074, India.
Strengthening the fight against CLABSI: Insights from comparative study of UVC vs PICC line.
Indian Pediatr
December 2024
Department of Neonatology, Pramukhswami Medical College, Shree Krishna Hospital, Bhaikaka University, Karamsad, Anand, Gujarat, 388325
Emerging prospects of mRNA cancer vaccines: mechanisms, formulations, and challenges in cancer immunotherapy.
Front Immunol
December 2024
School of Life Sciences, Henan University, Kaifeng, Henan, China.
Cancer continues to pose an alarming threat to global health, necessitating the need for the development of efficient therapeutic solutions despite massive advances in the treatment. mRNA cancer vaccines have emerged as a hopeful avenue, propelled by the victory of mRNA technology in COVID-19 vaccines. The article delves into the intricate mechanisms and formulations of cancer vaccines, highlighting the ongoing efforts to strengthen mRNA stability and ensure successful translation inside target cells.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!